Lieve Temmerman

1.3k total citations
22 papers, 945 citations indexed

About

Lieve Temmerman is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lieve Temmerman has authored 22 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Lieve Temmerman's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (3 papers). Lieve Temmerman is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (3 papers). Lieve Temmerman collaborates with scholars based in Netherlands, Germany and United Kingdom. Lieve Temmerman's co-authors include Erik A.L. Biessen, Esther Lutgens, Bart Legein, Nadia Rosenthal, Robert D. Sampson, Michael Schneider, Laura Barberi, Joanne Tonkin, Antonio Musarò and Enrique Gallego-Colón and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Circulation Research.

In The Last Decade

Lieve Temmerman

20 papers receiving 935 citations

Peers

Countries citing papers authored by Lieve Temmerman

Since Specialization

Citations

This map shows the geographic impact of Lieve Temmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieve Temmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieve Temmerman more than expected).

Fields of papers citing papers by Lieve Temmerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieve Temmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieve Temmerman. The network helps show where Lieve Temmerman may publish in the future.

Co-authorship network of co-authors of Lieve Temmerman

This figure shows the co-authorship network connecting the top 25 collaborators of Lieve Temmerman. A scholar is included among the top collaborators of Lieve Temmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieve Temmerman. Lieve Temmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells 2025 ·Frontiers in Immunology ·(unknown), (unknown), Adrien Guillot, Marion J. Gijbels, Judith C. Sluimer, Lieve Temmerman, Pieter Goossens, Barend Mees, Frank Tacke, Vera Jankowski, Joachim Jankowski, Marjo M. P. C. Donners, Erik A.L. Biessen	0
2	Colony stimulating factor 1 receptor ( Csf1r ) expressing cell ablation in mafia (macrophage‐specific Fas‐induced apoptosis) mice alters monocyte landscape and atherosclerotic lesion characteristics 2024 ·European Journal of Immunology ·(unknown), (unknown), Lieve Temmerman, (unknown), Beatriz Bermúdez, Ilze Bot, Timo Rademakers, Erwin Wijnands, Leon J. Schurgers, Barend Mees, Theo J.C. van Berkel, Pieter Goossens, Erik A.L. Biessen	0
3	Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction‐associated steatohepatitis 2024 ·FEBS Journal ·(unknown), (unknown), (unknown), Tulasi Yadati, Gert B. Eijkel, Benjamin Balluff, Roger Godschalk, Lieve Temmerman, Erik A.L. Biessen, Aditya Kulkarni, Jan Theys, Tom Houben, Berta Cillero‐Pastor, Ronit Shiri‐Sverdlov	1
4	Monocyte heterogeneity in cardiovascular disease 2023 ·Cardiovascular Research ·(unknown), Suzan Wetzels, Lieve Temmerman, Erik A.L. Biessen, Pieter Goossens	31
5	In situ lipid-loading activates peripheral dendritic cell subsets characterized by cellular ROS accumulation but compromises their capacity to prime naïve T cells 2023 ·Free Radical Biology and Medicine ·Anette Christ, Sanne L. Maas, Han Jin, (unknown), Bart Legein, Erwin Wijnands, Lieve Temmerman, (unknown), Aaron Isaacs, Martin Zenke, Monika Stoll, Erik A.L. Biessen, Emiel P. C. van der Vorst	3
6	GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis 2023 ·Frontiers in Immunology ·(unknown), Han Jin, (unknown), Lieve Temmerman, Barend Mees, Casper G. Schalkwijk, (unknown), Thorsten Berg, Pieter Goossens, Marjo M. P. C. Donners, Erik A.L. Biessen	10
7	Culture density influences the functional phenotype of human macrophages 2023 ·Frontiers in Immunology ·(unknown), Lieve Temmerman, (unknown), (unknown), Chang Lu, Judith C. Sluimer, Pieter Goossens, Erik A.L. Biessen	3
8	Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages 2022 ·Proceedings of the National Academy of Sciences ·Xanthe A.M.H. van Dierendonck, Frank Vrieling, (unknown), Lei Deng, (unknown), (unknown), Lieve Temmerman, Suzan Wetzels, Erik A.L. Biessen, Sander Kersten, Rinke Stienstra	97
9	Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Javier Perales-Patón, Lieve Temmerman, Yanal Ghosheh, Kim van Kuijk, Marion J. Gijbels, Peter Carmeliet, Klaus Ley, Julio Sáez-Rodríguez, Judith C. Sluimer	9
10	Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity 2021 ·Cells ·Armand M. G. Jaminon, Asim Cengiz Akbulut, (unknown), Rafael Kramann, Erik A.L. Biessen, Lieve Temmerman, Barend Mees, Vincent Brandenburg, (unknown), Willi Jahnen‐Dechent, J. Floege, Jouni Uitto, Chris Reutelingsperger, Leon J. Schurgers	8
11	A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis 2021 ·Cells ·(unknown), Thomas Theelen, Kim van Kuijk, Lieve Temmerman, (unknown), Marion J. Gijbels, Christer Betsholtz, Erik A.L. Biessen, Judith C. Sluimer	7
12	Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells 2019 ·Scientific Reports ·(unknown), (unknown), Ilze Bot, Han Jin, Aimée J P M Franssen, Martine Bot, Saskia C.A. de Jager, Ivan Dzhagalov, You-Wen He, Bart J.M. van Vlijmen, Marion J. Gijbels, Chris Reutelingsperger, Theo J.C. van Berkel, Judith C. Sluimer, Lieve Temmerman, Erik A.L. Biessen	5
13	Leukocyte Bim deficiency does not impact atherogenesis in ldlr −/− mice, despite a pronounced induction of autoimmune inflammation 2017 ·Scientific Reports ·Lieve Temmerman, (unknown), Ilze Bot, Bart J.M. van Vlijmen, (unknown), Martine Bot, Kim L. L. Habets, Tom G. Keulers, Johan van der Vlag, Thomas G. Cotter, Theo J.C. van Berkel, Erik A.L. Biessen	5
14	Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization 2015 ·Molecular Therapy ·Joanne Tonkin, Lieve Temmerman, Robert D. Sampson, Enrique Gallego-Colón, Laura Barberi, Daniel Bilbao, Michael Schneider, Antonio Musarò, Nadia Rosenthal	248
15	Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice 2015 ·Scientific Reports ·Bart Legein, Edith M. Janssen, Thomas Theelen, Marion J. Gijbels, (unknown), Jared Klarquist, Cassandra M. Hennies, Kristiaan Wouters, Tom Seijkens, Erwin Wijnands, Judith C. Sluimer, Esther Lutgens, Martin Zenke, Kai Hildner, Erik A.L. Biessen, Lieve Temmerman	21
16	Inflammation and immune system interactions in atherosclerosis 2013 ·Cellular and Molecular Life Sciences ·Bart Legein, Lieve Temmerman, Erik A.L. Biessen, Esther Lutgens	235
17	Dendritic Cells in Cardiovascular Diseases 2013 ·Circulation ·Anette Christ, Lieve Temmerman, Bart Legein, Mat J.A.P. Daemen, Erik A.L. Biessen	18
18	Plasmacytoid Dendritic Cells Protect Against Atherosclerosis by Tuning T-Cell Proliferation and Activity 2011 ·Circulation Research ·Isabelle Daissormont, Anette Christ, Lieve Temmerman, (unknown), Tom Seijkens, Marco Manca, Mat Rousch, Marjorie Poggi, Louis Boon, Chris van der Loos, Mat J.A.P. Daemen, Esther Lutgens, Bente Halvorsen, Pål Aukrust, Edith M. Janssen, Erik A.L. Biessen	107
19	Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels 2010 ·Growth Hormone & IGF Research ·Lieve Temmerman, Esfir Slonimsky, Nadia Rosenthal	29
20	Antioxidant Amelioration of Dilated Cardiomyopathy Caused by Conditional Deletion of NEMO/IKKγ in Cardiomyocytes 2009 ·Circulation Research ·Paschalis Kratsios, Marion Huth, Lieve Temmerman, Ekaterina Salimova, Mumna Al Banchaabouchi, Andrea Sgoifo, Massimo Manghi, Keiichiro Suzuki, Nadia Rosenthal, Foteini Mourkioti	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact